1. Farnsworth, W.E.: Personal communication
2. Fredholm, B., Jensen, G., Lindskog, M., Müntzing, J.: Effects of estramustine phosphate (Estracyt®) on growth of DMBA-induced mammary tumours in rats. Acta pharmacol. (Kbh.) 35 (1974) (abstract)
3. Jönsson, G., Olsson, A.M., Luttropp, W., Cekan, Z., Purvis, K., Diczfalusy, E.: Treatment of prostatic carcinoma with various types of estrogen derivatives. II Steroid levels. Vitam. and Horm. 33, 351 (1975)
4. Kirdani, R.Y., Müntzing, J., Verkarakis, M.J., Murphy, G.P., Sandberg, A.A.: Studies on the antiprostatic action of Estracyt, a nitrogen mustard of estradiol. Cancer Res. 34, 1031–1037 (1974)
5. Mittelman, A., Shukla, S.K., Welwaart, K., Murphy, G.P.: Oral estramustine phosphate (NSC-89199) in the treatment of advanced (Stage D) carcinoma of the prostate. Cancer Chemother. Rep. Part 1, 59, 219–223 (1975)